FXYD3 and intrahepatic cholangiocarcinoma: We assessed the mRNA levels of FXYD3 in 25 pairs of ICC and adjacent nontumor samples using qRT‐PCR, and observed a substantial increase in FXYD3 mRNA levels in ICC samples compared to nontumor samples (Figure 2A).